Detecting viral contaminants in biologic-based medicines-and identifying their source-requires a holistic testing approach.
Richard Adair
Advertisement
Richard Adair is virology and technical support manager, SGS Life Sciences, Glasgow, Scotland.
Articles by Richard Adair
Advertisement
Latest Updated Articles
Control Viral Contaminants with Effective TestingPublished: October 1st 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
